Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study).
Suzuki T, Kanemitsu Y, Sugimoto N, Masaki K, Akamatsu T, Tsurumaki H, Majima S, Ito K, Iwata T, Shimizu H, Wakayama H, Amakusa Y, Koizumi Y, Mori Y, Fukumitsu K, Fukuda S, Uemura T, Tajiri T, Ohkubo H, Oguri T, Hisada T, Shirai T, Fukunaga K, Nagase H, Niimi A.
Suzuki T, et al.
Allergy Asthma Immunol Res. 2026 May;18(3):362-378. doi: 10.4168/aair.2026.18.3.362.
Allergy Asthma Immunol Res. 2026.
PMID: 42223036
Free PMC article.
PURPOSE: Coronavirus disease 2019 (COVID-19) mRNA vaccines have reduced the severity and mortality of severe acute respiratory syndrome coronavirus 2 infection. ...RESULTS: Patients with asthma had a higher COVID-19 mRNA vaccine-associated exacerbation …
PURPOSE: Coronavirus disease 2019 (COVID-19) mRNA vaccines have reduced the severity and mortality of severe acute respiratory …